Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Fermer
  2. Aide
  2. Aide
Nikkei 225
45 003,38
+0,48%
Indices
Chiffres-clés
+ fortes hausses et baisses SBF 120

Transgene Presents its Individualized Immunotherapy, TG4050, at the Annual Neoantigen Based Therapies Summit
information fournie par Boursorama CP 05/11/2020 à 07:30

Strasbourg, France, November 5, 2020, 7:30 am CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that its Executive Vice President and Chief Scientific Officer, Eric Quéméneur, Pharm.D., PhD, will present today at the virtual 5th Annual Neoantigen Based Therapies Summit.

Presentation

- Title: Viral Immunotherapy Meets AI Technology
- Session: Clinical Translation - Utilizing Different Delivery Platforms to Enhance Clinical
- Timing: November 5th at 11.45 am ET / 5.45 pm CET

.../...

Valeurs associées

TRANSGENE
1,145 EUR Euronext Paris +4,09%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

Cette liste ne contient aucune valeur.
Chargement...

Pages les plus populaires

L'offre BoursoBank